QUOTE AND NEWS
PR Newswire  Nov 12  Comment 
CRANBURY, N.J., Nov. 12 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company's President and Chief Executive Officer, John F. Crowley, will be presenting at the upcoming Lazard Capital Markets 6th Annual
FierceBiotech  Oct 30  Comment 
Cranbury, NJ-based Amicus Therapeutics (FOLD) said in its third quarter earnings report that its collaboration with Shire is over. The two companies were partnered on three lead pharmacological chaperone compounds for the treatment of lysosomal...
PR Newswire  Oct 26  Comment 
CRANBURY, N.J., Oct. 26 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD) will announce third quarter 2009 financial results after the regular close of markets on Thursday, October 29, 2009. The results announcement will be followed by a
newratings.com  Oct 5  Comment 
NEW YORK, October 5 (newratings.com) - Analysts at Wedbush Morgan downgrade Amicus Therapeutics (ticker: FOLD) from "outperform" to "underperform." The target price has been reduced from $17 to $3.5. [more]
FierceBiotech  Oct 5  Comment 
Shares of Amicus Therapeutics (FOLD) plunged 33 percent this morning after it announced that its therapy for Gaucher disease appeared to work in only one out of the 18 patients who completed a mid-stage trial. Lazard Capital Markets analyst...
Wall Street Law Blog  Oct 5  Comment 
You can sue primary violators of Rule 10b-5.  You cannot sue those who merely aid and abet a securities fraud.  Trouble is, the line between primary violators and those who aid and abet a securities fraud moves like the San Andreas fault. The...
StreetInsider.com  Oct 2  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Amicus+%28FOLD%29+Reports+Preliminary+Results+of+Phase+2+Trial+on+Plicera%28TM%29/4990258.html for the full story.
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 


You may also be interested in articles related to Amicus Therapeutics Inc (FOLD):
 
FOLD AT A GLANCE
 
 
 
 
 
 
 
 




References

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki